Regional white matter and gray matter damage and cognitive performances in multiple sclerosis according to sex

Nicolò Tedone1, Paolo Preziosa1,2,3, Alessandro Meani1

  • 1Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Molecular Psychiatry
|February 22, 2023
PubMed

Insights

Cognitive impairment in multiple sclerosis (MS) differs by sex. White matter lesions and microstructural abnormalities impact cognition more in female MS patients, while gray matter atrophy affects males differently.

Area of Science:

  • Neuroimaging
  • Neurology
  • Cognitive Neuroscience

Background:

  • Multiple sclerosis (MS) is a chronic neurological disease affecting white matter (WM), normal-appearing white matter (NAWM), and gray matter (GM).
  • Cognitive impairment is a common MS symptom, but sex-related differences in its underlying neurobiological mechanisms are not fully understood.
  • Understanding these sex differences is crucial for personalized MS management.

Purpose of the Study:

  • To investigate sex-specific contributions of WM lesions, NAWM microstructural abnormalities, and GM atrophy to cognitive performance in MS patients.
  • To identify potential sex-related differences in the association between brain pathology and cognitive deficits in MS.

Main Methods:

  • 287 MS patients and 172 healthy controls (HC) underwent 3.0T brain MRI and neuropsychological testing.
  • Voxel-wise analyses examined sex-related differences in the association of cognitive performance with WM lesions, NAWM fractional anisotropy (FA), and GM volumes.
  • Statistical significance was determined using a family-wise error (FWE) corrected p-value < 0.01.

Main Results:

  • No significant overall difference in cognitive impairment rates between male and female MS patients.
  • Male MS patients showed worse verbal memory, while females performed worse on verbal fluency tasks.
  • Both sexes exhibited cognitive decline associated with WM lesions, reduced NAWM FA, and GM atrophy, with stronger associations in females for global cognition and verbal memory.
  • Cortical GM atrophy linked to cognitive decline in males, whereas deep GM atrophy was more relevant in females.

Conclusions:

  • While overall cognitive impairment rates are similar, specific cognitive domains and their neurobiological underpinnings differ between sexes in MS.
  • Focal WM lesions and diffuse NAWM abnormalities appear more critical in explaining cognitive impairment in female MS patients.
  • Sex-specific neuroimaging markers are important for understanding and potentially treating cognitive dysfunction in MS.